Atlas Trials

EGFR PACC

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch EGFR PACC

RecordFirmDate
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations (NCT07185997)ArriVent BioPharma, Inc.2025-12-17

Track EGFR PACC automatically

Every clearance here is in the API, with alerts when new ones post.